180 related articles for article (PubMed ID: 24036152)
1. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
[TBL] [Abstract][Full Text] [Related]
2. A butyrophilin family member critically inhibits T cell activation.
Yamazaki T; Goya I; Graf D; Craig S; Martin-Orozco N; Dong C
J Immunol; 2010 Nov; 185(10):5907-14. PubMed ID: 20944003
[TBL] [Abstract][Full Text] [Related]
3. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS.
Wang S; Zhu G; Chapoval AI; Dong H; Tamada K; Ni J; Chen L
Blood; 2000 Oct; 96(8):2808-13. PubMed ID: 11023515
[TBL] [Abstract][Full Text] [Related]
5. The cluster of BTN genes in the extended major histocompatibility complex.
Rhodes DA; Stammers M; Malcherek G; Beck S; Trowsdale J
Genomics; 2001 Feb; 71(3):351-62. PubMed ID: 11170752
[TBL] [Abstract][Full Text] [Related]
6. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway.
Challita-Eid PM; Penichet ML; Shin SU; Poles T; Mosammaparast N; Mahmood K; Slamon DJ; Morrison SL; Rosenblatt JD
J Immunol; 1998 Apr; 160(7):3419-26. PubMed ID: 9531302
[TBL] [Abstract][Full Text] [Related]
7. Regulation of costimulation in the era of butyrophilins.
Arnett HA; Escobar SS; Viney JL
Cytokine; 2009 Jun; 46(3):370-5. PubMed ID: 19380239
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mouse and human B7-H3 genes.
Sun M; Richards S; Prasad DV; Mai XM; Rudensky A; Dong C
J Immunol; 2002 Jun; 168(12):6294-7. PubMed ID: 12055244
[TBL] [Abstract][Full Text] [Related]
9. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.
Nguyen T; Liu XK; Zhang Y; Dong C
J Immunol; 2006 Jun; 176(12):7354-60. PubMed ID: 16751379
[TBL] [Abstract][Full Text] [Related]
10. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
11. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
[TBL] [Abstract][Full Text] [Related]
12. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
Parra E; Wingren AG; Hedlund G; Björklund M; Sjögren HO; Kalland T; Sansom D; Dohlsten M
J Immunol; 1994 Sep; 153(6):2479-87. PubMed ID: 7521363
[TBL] [Abstract][Full Text] [Related]
13. B cells in teleost fish act as pivotal initiating APCs in priming adaptive immunity: an evolutionary perspective on the origin of the B-1 cell subset and B7 molecules.
Zhu LY; Lin AF; Shao T; Nie L; Dong WR; Xiang LX; Shao JZ
J Immunol; 2014 Mar; 192(6):2699-714. PubMed ID: 24532580
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
Nikcevich KM; Gordon KB; Tan L; Hurst SD; Kroepfl JF; Gardinier M; Barrett TA; Miller SD
J Immunol; 1997 Jan; 158(2):614-21. PubMed ID: 8992975
[TBL] [Abstract][Full Text] [Related]
15. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation.
Inobe M; Aoki N; Linsley PS; Ledbetter JA; Abe R; Murakami M; Uede T
J Immunol; 1996 Jul; 157(2):582-8. PubMed ID: 8752905
[TBL] [Abstract][Full Text] [Related]
16. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
17. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
[TBL] [Abstract][Full Text] [Related]
18. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation.
Smith IA; Knezevic BR; Ammann JU; Rhodes DA; Aw D; Palmer DB; Mather IH; Trowsdale J
J Immunol; 2010 Apr; 184(7):3514-25. PubMed ID: 20208008
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
20. MRC OX-2 defines a novel T cell costimulatory pathway.
Borriello F; Lederer J; Scott S; Sharpe AH
J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
